Newtyn Capital Partners, LP, Insider at MERRIMACK PHARMACEUTICALS INC (MACK), bought 1,420 shares at $5.97 ($8K) on 2022-06-17, disclosed to the SEC on 2022-06-21.
Open-market purchase of $8k MACK by Insider. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.45 | 223 | $1K | 14.8% |
| 2 | $5.45 | 297 | $2K | 19.7% |
| 3 | $5.97 | 385 | $2K | 28.0% |
| 4 | $5.97 | 515 | $3K | 37.5% |
| Total | $5.78 avg | 1,420 | $8K | 100% |
| Filing → |
| MACK | BUY | 2020-11-16 | $412K | — | Filing → |
| MACK | BUY | 2020-08-13 | $55K | — | Filing → |
| MACK | BUY | 2020-04-07 | $46K | — | Filing → |